Exclusive Interviews

In Part 1 of this Exclusive Interview, Dr. Robert Geho joins Diabetes in Control publisher Steve Freed at the 2016 Diabetes Symposium in Boston to discuss a new drug delivery system designed to deliver insulin molecules that are currently sold as commercial insulins to cells in the liver. Robert Geho, …

In part 3 of this Exclusive Interview about the new diabetes classification, facilitating the individual use of "evidence-based practice" to individually assess the situation of a specific patient, instead of allowing media supposition about a drug class -- such as SGLT-2s -- to dictate diabetes treatment.

In part 2 of this Exclusive Interview about the new diabetes classification, Dr. Stanley Schwartz explains the necessity of treating beta cell dysfunction even as early as prediabetes, but also needing health organizations to agree on the early use of certain treatments.

In part 1 of this Exclusive Interview, Dr. Stanley Schwartz explains how the current understanding of diabetes surpasses the diabetes classifications determined long ago. He explains how understanding the inner workings of a specific patient can determine the best therapy for that patient, whether diabetes classifications change or stay the same.

In this exclusive interview transcript, Dr. Stanley Schwartz discusses the proposed new diabetes classification, which seeks to not only just classify but to help in determining what type of treatment might be best for that patient.

In the conclusion of this Exclusive Interview, Kimberly Ward explains how Roche can help the patient with private insurance to get help obtaining a preferred co-pay for the Accu-Check system.

In part 3 of this exclusive interview, Dr. Faustman discusses how a cure based on the inexpensive BCG vaccine could permanently change type 1 treatment, and whether results could also apply to type 2.

In part 2 of this exclusive interview, Dr. Faustman discusses the challenges of dosing BCG correctly, and the difficulties of defeating autoimmunity in humans.

In part 1 of this exclusive interview, Dr. Faustman discusses her research and why an old tuberculosis vaccine may lead us to a cure for type 1.

In part 5 of this Exclusive Interview, Kimberly Ward explains how the Accu-Chek system helps the patient to manage their blood glucose.